Evaluation of a CD206-Targeted Peptide for PET Imaging of Macrophages in Syngeneic Mouse Models of Cancer.
暂无分享,去创建一个
A. Sorace | C. Yates | S. Lapi | A. Massicano | Ahmad Bin Salam | H. Lopez | S. Fernandez | H. Houson | J. Jaynes | Patrick N. Song | Carlos A. Gallegos | Candace C Parker | Addison Hunt
[1] Zhentao Yang,et al. Anti-PD-1/L1 lead-in before MAPK inhibitor combination maximizes antitumor immunity and efficacy. , 2021, Cancer cell.
[2] S. Lapi,et al. Positron Emission Tomography Imaging of Macrophages in Cancer , 2021, Cancers.
[3] P. Delvenne,et al. Extracellular HMGB1 blockade inhibits tumor growth through profoundly remodeling immune microenvironment and enhances checkpoint inhibitor-based immunotherapy , 2021, Journal for ImmunoTherapy of Cancer.
[4] E. Löyttyniemi,et al. Evaluation of [18F]F-DPA as a target for TSPO in head and neck cancer under normal conditions and after radiotherapy , 2020, European Journal of Nuclear Medicine and Molecular Imaging.
[5] Xikun Zhou,et al. Tumor-Associated Macrophages: Recent Insights and Therapies , 2020, Frontiers in Oncology.
[6] Jason B. White,et al. Mannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responses , 2020, Science Translational Medicine.
[7] N. Inui,et al. Macrophage Mannose Receptor CD206 Predicts Prognosis in Community-acquired Pneumonia , 2019, Scientific Reports.
[8] S. Barry,et al. Longitudinal immune characterization of syngeneic tumor models to enable model selection for immune oncology drug discovery , 2019, Journal of Immunotherapy for Cancer.
[9] Yibing Chen,et al. Tumor-associated macrophages: an accomplice in solid tumor progression , 2019, Journal of Biomedical Science.
[10] Huiyin Lan,et al. Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications , 2019, Journal of Hematology & Oncology.
[11] N. Devoogdt,et al. Clinical Translation of [68Ga]Ga-NOTA-anti-MMR-sdAb for PET/CT Imaging of Protumorigenic Macrophages , 2019, Molecular Imaging and Biology.
[12] X. Shao,et al. Tracking Macrophage Infiltration in a Mouse Model of Pancreatic Cancer with the Positron Emission Tomography Tracer [11C]PBR28. , 2018, The Journal of surgical research.
[13] N. Inui,et al. Macrophage mannose receptor, CD206, predict prognosis in patients with pulmonary tuberculosis , 2018, Scientific Reports.
[14] Yiping Yang,et al. Tumor-associated macrophages: implications in cancer immunotherapy. , 2017, Immunotherapy.
[15] Hongjuan Zhao,et al. RRx-001: a systemically non-toxic M2-to-M1 macrophage stimulating and prosensitizing agent in Phase II clinical trials , 2017, Expert opinion on investigational drugs.
[16] M. Mino‐Kenudson,et al. Type I collagen–targeted PET probe for pulmonary fibrosis detection and staging in preclinical models , 2017, Science Translational Medicine.
[17] W. Breeman,et al. Radiolabeling of DOTA-like conjugated peptides with generator-produced 68Ga and using NaCl-based cationic elution method , 2016, Nature Protocols.
[18] Murugesan V. S. Rajaram,et al. The inextricable axis of targeted diagnostic imaging and therapy: An immunological natural history approach. , 2016, Nuclear medicine and biology.
[19] Paul Kinahan,et al. Positron Emission Tomography: Current Challenges and Opportunities for Technological Advances in Clinical and Preclinical Imaging Systems. , 2015, Annual review of biomedical engineering.
[20] Jeffrey W Pollard,et al. Tumor-associated macrophages: from mechanisms to therapy. , 2014, Immunity.
[21] Thomas A. Wynn,et al. Macrophage biology in development, homeostasis and disease , 2013, Nature.
[22] Jeffrey W. Pollard,et al. Macrophage Diversity Enhances Tumor Progression and Metastasis , 2010, Cell.
[23] B. Monsarrat,et al. A New Generation of Melan-A/MART-1 Peptides That Fulfill Both Increased Immunogenicity and High Resistance to Biodegradation: Implication for Molecular Anti-Melanoma Immunotherapy1 , 2001, The Journal of Immunology.